Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.7 |
mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | 0.022 | 0.7 |
mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | -0.022 | 0.7 |
mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.058 | 0.7 |